TFX stock icon

Teleflex
TFX

$229.28
4.29%

Market Cap: 10.8B

 

About: Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Employees: 14,500

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 7 analysts
0
News positive %
of 4 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

5.99% more ownership

Funds ownership: 95.98% [Q4 2023] → 101.97% (+5.99%) [Q1 2024]

0% more funds holding

Funds holding: 465 [Q4 2023] → 465 (+0) [Q1 2024]

0% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 53

4% less repeat investments, than reductions

Existing positions increased: 158 | Existing positions reduced: 164

11% less capital invested

Capital invested by funds: $11.3B [Q4 2023] → $10.1B (-$1.2B) [Q1 2024]

39% less call options, than puts

Call options by funds: $5.65M | Put options by funds: $9.23M

67% less funds holding in top 10

Funds holding in top 10: 3 [Q4 2023] → 1 (-2) [Q1 2024]

Research analyst outlook

7 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$219
4%
downside
Avg. target
$251
9%
upside
High target
$285
24%
upside

7 analyst ratings

positive
43%
neutral
57%
negative
0%
Truist Securities
Richard Newitter
5%upside
$240
Hold
Maintained
16 Jul 2024
Truist Securities
Richard Newitter
2%upside
$235
Hold
Maintained
9 Jul 2024
Piper Sandler
Matt O'Brien
7%upside
$245
Overweight
Upgraded
1 Jul 2024
Truist Securities
Richard Newitter
4%downside
$219
Hold
Maintained
3 May 2024
JMP Securities
David Turkaly
24%upside
$285
Market Outperform
Reiterated
23 Feb 2024

Financial journalist opinion

Based on 4 articles about TFX published over the past 30 days